An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (0)
  • Podcast (0)
  • Publications (15)
  • Training (0)
  • User case (0)
  • User meeting (0)
  • Webinar (1)
  • White paper (1)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (3)
  • Breast (2)
  • Gastro-intestinal (7)
  • Genito-urinary (4)
  • Gynecological (0)
  • (-) Head and neck (17)
  • Hodgkin and Non-Hodgkin lymphoma (2)
  • Ocular (0)
  • Pediatric (3)
  • Reirradiation (1)
  • Sarcomas (0)
  • Thoracic (12)
  • Reset filters
  • (-) IMRT
  • (-) Head and neck

Treating head and neck cancer with proton therapy

30/12/2020
/ White Paper
/
Toxicity
IMRT
Dosimetry

Proton particles do not deposit exit dose, which allows proton therapy to spare normal tissues distal to the tumor target. This is particularly useful for...

Model-based for nasopharyngeal carcinoma

24/09/2020
/ Webinar
/
Model-based approach
VMAT
ARC therapy
IMRT
IMPT

Comparing the oncologic outcomes of proton therapy and intensity-modulated radiation therapy for head and neck squamous cell carcinoma.

08/04/2024
/ Publications
/
IMRT
IMPT

To compare the oncologic outcomes between proton therapy and intensity-modulated radiation therapy (IMRT) for head and neck squamous cell carcinoma (HNSCC)...

Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy.

14/06/2021
/ Publications
/
IMPT
IMRT
Toxicity

This review suggested that IMPT could de-intensifies treatment through dose de-escalation to normal tissues without compromising dose to the primary tumor and...

Proton Therapy for Squamous Cell Carcinoma of the Head and Neck: Early Clinical Experience and Current Challenges.

14/05/2022
/ Publications
/
IMRT
Reirradiation

A significant reduction of toxicities, such as xerostomia, dysgeusia and feeding tube placement has been reported in studies of definitive PT for NPSCC...

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.

14/11/2022
/ Publications
/
IMPT
IMRT
Toxicity
Survival

Among the 292 patients with nonmetastatic oropharyngeal cancer of which 272 [93%] were HPV–positive tumors, 58 patients (20%) were treated with IMPT and 234 (80...

Long-term outcomes of modern multidisciplinary management of sinonasal cancers: The M. D. Anderson experience.

14/07/2023
/ Publications
/
Toxicity
IMRT

This is study retrospectively analyzed 311 patients with sinonasal tumors treated with IMRT or PT. With median follow-up of 75 months, this study reported 10...

Pagination

  • Previous page ‹
    • Page 1
    • Current page 2
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies